ATE555792T1 - Prostaglandin f2 alpha derivat enthaltende produkte - Google Patents
Prostaglandin f2 alpha derivat enthaltende produkteInfo
- Publication number
- ATE555792T1 ATE555792T1 AT05819874T AT05819874T ATE555792T1 AT E555792 T1 ATE555792 T1 AT E555792T1 AT 05819874 T AT05819874 T AT 05819874T AT 05819874 T AT05819874 T AT 05819874T AT E555792 T1 ATE555792 T1 AT E555792T1
- Authority
- AT
- Austria
- Prior art keywords
- prostaglandin
- derivative
- component
- aqueous liquid
- liquid preparation
- Prior art date
Links
- 150000003169 prostaglandin F2α derivatives Chemical class 0.000 title 1
- 239000007788 liquid Substances 0.000 abstract 3
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 abstract 3
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 abstract 3
- PXGPLTODNUVGFL-YNNPMVKQSA-N prostaglandin F2alpha Chemical class CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O PXGPLTODNUVGFL-YNNPMVKQSA-N 0.000 abstract 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract 2
- 239000005977 Ethylene Substances 0.000 abstract 2
- 229910052731 fluorine Inorganic materials 0.000 abstract 2
- 125000001153 fluoro group Chemical group F* 0.000 abstract 2
- 239000011347 resin Substances 0.000 abstract 2
- 229920005989 resin Polymers 0.000 abstract 2
- 229920001038 ethylene copolymer Polymers 0.000 abstract 1
- 229920001155 polypropylene Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L23/00—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- C08L23/02—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
- C08L23/10—Homopolymers or copolymers of propene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L53/00—Compositions of block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2203/00—Applications
- C08L2203/02—Applications for biomedical use
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L23/00—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- C08L23/02—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
- C08L23/10—Homopolymers or copolymers of propene
- C08L23/14—Copolymers of propene
- C08L23/142—Copolymers of propene at least partially crystalline copolymers of propene with other olefins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
- Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004374009 | 2004-12-24 | ||
| PCT/JP2005/023704 WO2006068266A1 (ja) | 2004-12-24 | 2005-12-26 | プロスタグランジンＦ２ａ誘導体含有製品 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE555792T1 true ATE555792T1 (de) | 2012-05-15 |
Family
ID=36601858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05819874T ATE555792T1 (de) | 2004-12-24 | 2005-12-26 | Prostaglandin f2 alpha derivat enthaltende produkte |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20070244196A1 (de) |
| EP (1) | EP1829545B1 (de) |
| KR (1) | KR101283874B1 (de) |
| CN (1) | CN101175496A (de) |
| AT (1) | ATE555792T1 (de) |
| CA (1) | CA2592474C (de) |
| DK (1) | DK1829545T3 (de) |
| ES (1) | ES2386148T3 (de) |
| NO (1) | NO338832B1 (de) |
| PL (1) | PL1829545T3 (de) |
| PT (1) | PT1829545E (de) |
| RU (1) | RU2391983C2 (de) |
| SI (1) | SI1829545T1 (de) |
| WO (1) | WO2006068266A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2127638A1 (de) | 2008-05-30 | 2009-12-02 | Santen Pharmaceutical Co., Ltd | Verfahren und Zusammensetzung zur Behandlung von Augenhochdruck und Glaukom |
| CN106929477B (zh) * | 2017-03-20 | 2020-01-10 | 江南大学 | 一株抗前列腺素F2α的特异性单克隆抗体杂交瘤细胞株WXX-2及其应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2886035A (en) * | 1955-07-29 | 1959-05-12 | Cutter Lab | Venoclysis apparatus |
| US2985920A (en) * | 1958-03-26 | 1961-05-30 | Seiberling Rubber Co | Method of making a cored heel |
| US4310543A (en) * | 1980-10-09 | 1982-01-12 | Hoffmann-La Roche Inc. | Prostaglandin compositions |
| GB2209939B (en) * | 1987-09-18 | 1992-01-02 | R Tech Ueno Ltd | The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents |
| US5565492A (en) * | 1988-07-18 | 1996-10-15 | Alcon Laboratories, Inc. | Prostaglandin combinations in glaucoma therapy |
| JPH06285135A (ja) * | 1993-03-31 | 1994-10-11 | Kyoraku Co Ltd | 薬液用プラスチック容器 |
| US5486540A (en) * | 1993-10-28 | 1996-01-23 | Allergan, Inc. | Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents |
| US6235781B1 (en) * | 1998-07-14 | 2001-05-22 | Alcon Laboratories, Inc. | Prostaglandin product |
| CA2295512C (en) * | 1998-07-14 | 2009-05-26 | Alcon Laboratories, Inc. | Prostaglandin product |
| EP1321144B1 (de) * | 2000-09-13 | 2010-12-08 | Santen Pharmaceutical Co., Ltd. | Augentropfen |
| JP3876355B2 (ja) * | 2000-09-13 | 2007-01-31 | 参天製薬株式会社 | 点眼液 |
| WO2002022106A2 (en) * | 2000-09-14 | 2002-03-21 | Novartis Ag | Stable ophthalmic preparation |
| TW586946B (en) * | 2000-12-22 | 2004-05-11 | Novartis Ag | Process to improve stability |
| JP2003138074A (ja) * | 2001-10-30 | 2003-05-14 | Japan Polychem Corp | 医療用延伸ブロー容器 |
| US20060199863A1 (en) * | 2003-07-31 | 2006-09-07 | Santen Pharmaceutical Co., Ltd. | Product containing prostaglandin |
| US20050049311A1 (en) * | 2003-09-03 | 2005-03-03 | Pharmacia & Upjohn Company | Medicinal products comprising prostaglandin compositions and methods of packaging such compositions |
-
2005
- 2005-12-26 AT AT05819874T patent/ATE555792T1/de active
- 2005-12-26 RU RU2007128318/15A patent/RU2391983C2/ru active
- 2005-12-26 EP EP05819874A patent/EP1829545B1/de not_active Expired - Lifetime
- 2005-12-26 PT PT05819874T patent/PT1829545E/pt unknown
- 2005-12-26 ES ES05819874T patent/ES2386148T3/es not_active Expired - Lifetime
- 2005-12-26 PL PL05819874T patent/PL1829545T3/pl unknown
- 2005-12-26 CA CA2592474A patent/CA2592474C/en not_active Expired - Lifetime
- 2005-12-26 WO PCT/JP2005/023704 patent/WO2006068266A1/ja not_active Ceased
- 2005-12-26 SI SI200531522T patent/SI1829545T1/sl unknown
- 2005-12-26 CN CNA2005800444073A patent/CN101175496A/zh active Pending
- 2005-12-26 DK DK05819874.8T patent/DK1829545T3/da active
- 2005-12-26 KR KR1020077015846A patent/KR101283874B1/ko not_active Expired - Lifetime
-
2007
- 2007-06-18 US US11/821,511 patent/US20070244196A1/en not_active Abandoned
- 2007-07-19 NO NO20073767A patent/NO338832B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2007128318A (ru) | 2009-01-27 |
| EP1829545B1 (de) | 2012-05-02 |
| PT1829545E (pt) | 2012-05-21 |
| KR101283874B1 (ko) | 2013-07-08 |
| US20070244196A1 (en) | 2007-10-18 |
| DK1829545T3 (da) | 2012-07-23 |
| CN101175496A (zh) | 2008-05-07 |
| PL1829545T3 (pl) | 2012-09-28 |
| EP1829545A1 (de) | 2007-09-05 |
| NO338832B1 (no) | 2016-10-24 |
| NO20073767L (no) | 2007-09-14 |
| CA2592474A1 (en) | 2006-06-29 |
| EP1829545A4 (de) | 2009-07-22 |
| SI1829545T1 (sl) | 2012-08-31 |
| ES2386148T3 (es) | 2012-08-10 |
| RU2391983C2 (ru) | 2010-06-20 |
| CA2592474C (en) | 2013-08-13 |
| KR20070093997A (ko) | 2007-09-19 |
| WO2006068266A1 (ja) | 2006-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20073353L (no) | Produkt som har prostaglandin som har fluoratom i molekyl | |
| DE60217087D1 (en) | Metallsalze von hexahydrophthalsäure als keimbildende additive für kristalline thermoplaste | |
| WO2007062399A3 (en) | Oncogenic ras-specific cytotoxic compound and methods of use thereof | |
| WO2010014807A3 (en) | Perfume compositions comprising functional perfume components | |
| ATE404090T1 (de) | Einwegbesteck | |
| WO2007006926A3 (fr) | Nouveaux derives de 2,4-dianilinopyrimidines, leur preparation, a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk | |
| BRPI0407890A (pt) | kit formador de espuma contendo um dosador formador de espuma e uma composição com alto teor de tensoativo | |
| WO2007112914A3 (en) | Ceramide kinase modulation | |
| WO2007130568A3 (en) | Fabric treatment dispensing package | |
| RU2009138047A (ru) | Стабилизация витамина в12 | |
| WO2008139992A1 (ja) | 油類用添加剤およびこれを含有する潤滑油 | |
| MA32776B1 (fr) | Inhibiteurs de l'akt et de la p70 s6 kinase | |
| CY1111168T1 (el) | Παραγωγο βενζιμιδαζολιου και χρηση αυτου | |
| ES2191435T3 (es) | Mezcla herbicida que contiene un derivado de benzoilo 3-heterociclil-substituido. | |
| AR110068A2 (es) | 2-amino-7,8-dihidro-6h-pirido[4,3-d]pirimidina-5-onas | |
| BRPI0418474A (pt) | solução aquosa parenteral estável | |
| EP2289975A3 (de) | Organpolysiloxanverbindung und Amidoaminverbindung sowie kosmetische Zubereitung | |
| ATE555792T1 (de) | Prostaglandin f2 alpha derivat enthaltende produkte | |
| GB0226203D0 (en) | Improvements in or relating to articles | |
| ATE402220T1 (de) | Granulatmasse | |
| WO2007019191A3 (en) | Thiazolopyrimidine kinase inhibitors | |
| JP2010053171A5 (de) | ||
| WO2008090732A1 (ja) | 医薬組成物 | |
| EP1840185A4 (de) | Flüssigkristalline zusammensetzung | |
| WO2007059896A3 (de) | Agrochemische zusammensetzung |